Sana Biotechnology inks $50M deal for precise gene editing system from Beam Therapeutics
GeekWire
OCTOBER 19, 2021
Sana Biotechnology has a new $50 million tool in its toolbox. That’s according to a study in Nature Communications led by CRISPR pioneer Feng Zhang at the Broad Institute of MIT and Harvard, which has licensed its technology to Beam. The application with the U.S. Sana CEO and president Steve Harr. Sana Photo).
Let's personalize your content